Background
In experimental animal studies, potassium has been demonstrated to protect against the development of atherosclerosis through a variety of mechanisms. Data regarding the role of potassium in the development of human atherosclerosis are sparse. The objective of this study was to determine the association between plasma potassium levels and angiographically defined coronary artery disease (CAD).
Methods
In a cohort of 389 male patients undergoing coronary angiography for a variety of clinical indications, the association between baseline serum potassium levels and the extent of angiographically defined atherosclerosis was analyzed. Adjustments were made for clinical and laboratory variables (including inflammatory markers) known to be associated with atherosclerosis.
results
By multivariate logistic regression analysis, baseline serum potassium levels were an independent predictor of the presence of multivessel disease (odds ratio (OR) 1.31, 95% confidence interval (CI) 1.01-1.69; P < 0.05). In addition, in the non-myocardial infarction subpopulation of patients, serum potassium was also an independent predictor of the presence of multivessel disease by multivariate logistic regression analysis (OR 1.34, 95% CI, 1.02-1.76; P < 0.05). In the myocardial infarction (MI) subpopulation, serum potassium was not a predictor of multivessel disease, possibly due to the confounding effect of hypokalemia known to be present during MI.
conclusions
These data demonstrate that a simple baseline serum potassium level is independently associated with the presence of multivessel disease, even in the context of clinical CAD risk factors and other established inflammatory markers. articles Serum Potassium Levels and Angiographic Findings biomarkers in patients with known or suspected coronary artery disease (CAD). The study population and design have been previously described in detail elsewhere. 7 The study was conducted at an urban Veterans Administration Medical Center and was approved by the local institutional review board. Written informed consent was obtained from all patients. All patients referred to the cardiac catheterization laboratory for coronary angiography at the Bronx Veterans Affairs Medical Center between 13 January 1999 and 17 October 2002 were eligible for inclusion in the database. Patients with active gastrointestinal bleeding or a hemoglobin concentration <8 g/dl were excluded. During the period of study enrollment, a total of 523 consecutive male patients underwent diagnostic coronary angiography. Of these 523 patients, 50 could not be enrolled because of an unexpected loss of key study personnel between 29 January 2001 and 2 July 2001. Of the remaining 473 patients, 84 were either unwilling or unable to provide informed consent. Thus, a total of 389 patients provided informed consent and constituted the total population from which the database was derived. Detailed clinical and demographic information was obtained on all patients by interview as well as review of the computerized medical records (see below for description of clinical, laboratory, and angiographic variables). Fasting blood was obtained from the patients at the time of angiography and the plasma stored at −70 °C for subsequent analysis.
Blood sampling. After an overnight fast of at least 12 h, blood was obtained from all patients enrolled in the study. Blood was collected from the arterial sheath (after a 5 ml discard) at the time of angiography but prior to the injection of contrast material. Blood was immediately placed into vacutainer tubes, spun at 10g for 20 min in a cold centrifuge and the plasma aliquoted into multiple 1.5 ml Eppendorf tubes. The samples were subsequently stored at −70 °C until analysis at a later date.
Laboratory methods. Aliquoted plasma samples stored at −70 °C were thawed and, using commercially available ELISA kits, the levels of the following biomarkers were measured: tissue inhibitor of metalloproteinase-1 (TIMP-1; EMD Biosciences, San Diego, CA), matrix metalloproteinase-9 (MMP-9; EMD Biosciences, San Diego, CA), high-sensitivity C-reactive protein (hs-CRP; Life Diagnostics, West Chester, PA), myeloperoxidase (Assay Designs, Ann Arbor, MI), and insulin (Linco Diagnostics, St Charles, MO). The sensitivities of the TIMP-1, matrix metalloproteinase-9, hs-CRP, myeloperoxidase, and insulin assays were 0.0096 ng/ml, 0.1 ng/ml, 0.1 mg/l, 0.13 ng/ml, and 2 µU/ml, respectively. The intra-assay coefficients of variation for TIMP-1, matrix metalloproteinase-9, hs-CRP, myeloperoxidase, and insulin were <5.2%, <10%, <7.6%, <5.5%, and <7%, respectively. The white blood cell (WBC) count, the erythrocyte sedimentation rate, and the serum levels of potassium, sodium and blood urea nitrogen were determined by the central laboratories of the Bronx Veterans Administration Medical Center.
Definition of risk factors and clinical syndromes.
Patients were diagnosed with diabetes mellitus if they had ever been treated with an insulin regimen or oral hypoglycemic agents, or if they had a documented random glucose value ≥200 mg/dl on one or more occasion. Patients were diagnosed as hypertensive if they were documented to have a systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg on more than two occasions (but not during the angiogram procedure) or were already on antihypertensive therapy. Hyperlipidemia was diagnosed in patients who had been given lipid-lowering medication or had a history of total cholesterol levels >240 mg/dl. 8 Smoking was defined as the inhaled use of cigarettes, cigars, or pipes in any quantity. Smokers were classified as former only if they had not smoked at all in the 6 months preceding the date of angiography. Body mass index was calculated by dividing the weight of the patient in kilograms by the square of his height in meters. Congestive heart failure on presentation was defined as the presence of either radiographic or clinical evidence of pulmonary venous congestion within the preceding 24 h of angiography. MI on presentation was diagnosed by a history of chest discomfort and troponin I >1.0 ng/ml.
Angiographic data. All patients and their angiograms were graded as to the number of diseased coronary arteries, taking into account the left main, left anterior descending, left circumflex, and right coronary arteries (minimum = 0, maximum = 4). A coronary artery was considered diseased and then given a score of one if there was any obstructive lesion ≥50% in that artery or one of its major (≥2.5 mm) branches. Stenosis severity was determined by visual estimation (in at least two orthogonal views) and all angiograms were read by two angiographers working independently. Any differences in interpretation were subsequently reconciled by a third reviewer. The operators reading the angiograms were blinded to the results of any laboratory analyses. Left ventricular systolic function was assessed by contrast ventriculography and categorized as normal (ejection fraction ≥55%), mildly (ejection fraction 45-54%), moderately (ejection fraction 31-44%), or severely reduced (ejection fraction ≤30%). These four categories of left ventricular function were scored as 0, 1, 2, and 3, respectively.
Statistical methods. Summary statistics for the entire population were presented as two subgroups identified by the median serum potassium level as K ≤4.2 vs. K >4.2 mEq/l. Summary statistics for the continuous variables were presented both as means (with standard deviations) as well as medians (with interquartile ranges), and comparisons between the two groups were performed with the nonparametric Wilcoxon rank sum test. Data for the biomarkers were presented as median values, along with the 25th and 75th percentile values. Log transformation was applied to all biomarkers in order to reduce the skewness and kurtosis of the data. Categorical data were summarized as frequencies and percentages, and the comparisons between the two groups were performed with the Pearson χ 2 -test or the Fisher's exact test if the number of observations per cell was <5.
articles
Serum Potassium Levels and Angiographic Findings
The variables associated with the presence of multivessel CAD (i.e., the number of diseased coronary arteries ≥2) were identified by univariate logistic regression. The following baseline variables were studied by univariate analysis: age, race (defined as white or Hispanic compared to African American), family history of premature CAD, diabetes mellitus, hypertension, any history of tobacco use (active or past), active tobacco use, congestive heart failure on presentation, MI on presentation, aspirin use, β-blocker use, angiotensinconverting enzyme inhibitor use, angiotensin receptor blocker use, insulin therapy, left ventricular function, hyperlipidemia, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, total cholesterol, erythrocyte sedimentation rate, hs-CRP, myeloperoxidase, TIMP-1, matrix metalloproteinase-9, WBC count, body mass index, glomerular filtration rate derived by the Modification of Diet in Renal Disease equation, any diuretic use, potassium sparing diuretic use, any heparin use (low molecular weight heparin or unfractionated heparin), serum sodium, serum potassium, glucose, and insulin. Multivariate logistic regression with backward selection of variables was then used to identify those variables that were independently associated with the presence of multivessel CAD. The results were presented with ORs and 95% confidence intervals (CIs). Because statin use (as a variable) was part of the definition of hyperlipidemia used in this study, only hyperlipidemia was entered into multivariate models. For the similar reasons, presence of MI (and not troponin-I) was used in the multivariate analyses. For the inflammatory markers as well as for potassium, sodium and blood urea nitrogen, the ORs indicated an increment of one standard deviation in the respective log transformed variable.
All analyses used two-sided tests with an overall significance level of α = 0.05.
results

Baseline characteristics
In total, 389 men were enrolled in the study. Baseline clinical, laboratory and angiographic characteristics of the entire study population (as well as the non-MI subpopulation) stratified by the median serum potassium level are listed in Tables 1 and 2 .
In the entire cohort of patients, higher levels of serum potassium were seen in association with older age, diabetes mellitus, lower hs-CRP levels, multivessel CAD, lack of heparin use, and lower low-density lipoprotein levels. Similar associations were seen in the non-MI subpopulation of patients, but in addition higher levels of serum potassium were also seen in association with lower total cholesterol levels, lack of diuretic use and nonblack race. In the non-MI subpopulation of patients, there was no association between age and potassium levels.
association of serum potassium with multivessel disease in the entire cohort
To determine the association of serum potassium with multivessel disease on angiography, the number of diseased coronary arteries was categorized as 0 or 1 (normal, nonobstructive or single-vessel disease) vs. 2, 3, or 4 (multivessel disease). Using univariate logistic regression, the following baseline clinical and laboratory variables were associated with the presence of multivessel disease: age, β-blocker use, statin use, hypertension, hyperlipidemia, MI on presentation, left ventricular function, plasma TIMP-1 levels, plasma hs-CRP levels, plasma myeloperoxidase levels, WBC count, glomerular filtration rate derived by the Modification of Diet in Renal Disease equation and serum potassium levels. After adjustment for clinical variables (age, hypertension, left ventricular function, hyperlipidemia, and the presence of MI), serum potassium levels were independently associated with the presence of multivessel disease on angiography (OR 1.30, 95% CI 1.02-1.66; P < 0.05) ( Table 3) . After adjustment for both clinical and inflammatory variables (age, hypertension, left ventricular function, hyperlipidemia, myeloperoxidase, and WBC count), serum potassium remained an independent predictor of the presence of multivessel disease (OR 1.31, 95% CI 1.01-1.69; P < 0.05) ( Table 3) .
association of serum potassium with multivessel cad in the non-Mi subpopulation
Because of the known cellular fluxes in potassium during MI and the associated changes in serum level, we performed additional analyses of the association between serum potassium and multivessel CAD in the non-MI (n = 282) and MI (n = 107) sub-populations to determine whether the relation between potassium and CAD persisted in these two subgroups. In the non-MI subpopulation, the following baseline clinical and laboratory characteristics were associated with multivessel CAD on angiography by univariate analysis: age, race, β-blocker use, statin use, hypertension, hyperlipidemia, plasma TIMP-1 levels, plasma myeloperoxidase levels, and serum potassium levels. By multivariate analysis, serum potassium remained independently associated with the presence of multivessel disease on angiography by multivariate logistic regression analysis (OR 1.34, 95% CI, 1.02-1.76; P < 0.05) ( Table 4) .
In the MI subpopulation, serum potassium was not associated with the presence of multivessel CAD.
discussion
In the present study, we demonstrate that baseline serum potassium levels are independently associated with the presence of multivessel CAD in a broad and unselected population of patients referred for coronary angiography. To our knowledge, this is the first and only study of its kind in the literature demonstrating such an association. Importantly, we demonstrate that serum potassium levels are associated with the presence of multivessel CAD even after adjusting for a variety of established inflammatory markers shown to be predictors of angiographic CAD, suggesting that potassium levels may provide additional valuable information above and beyond traditional inflammatory markers.
The finding that serum potassium was an independent predictor of angiographic severity of CAD is intriguing. The mechanism for this association is unknown, and remains speculative. In broad terms, the association between hyperkalemia and atherosclerosis may be a causal one, a para-phenomenon, or it may represent a compensatory response to the underlying atherosclerotic process. As stated, exogenous potassium administration has been associated with a reduction in the development of atherosclerotic lesions. 1 High potassium diets have been shown to reduce endothelial injuries which allow adherence and infiltration of macrophages into the vascular wall of hypertensive animals, and thereby contribute to the reduction of vascular lesions. 9 The mechanism of this protection associated with high potassium diets is believed to be related to reduction in oxidative stress on the endothelium. 10 Given the protective effects of exogenous potassium on the development of atherosclerosis, the finding of a positive association between serum potassium levels and atherosclerosis in our clinical study appears to be somewhat counterintuitive. However, it may reflect a compensatory reaction of the body in response to underlying atherosclerotic triggers, perhaps mediated through the renin-angiotensinaldosterone system. Alternatively, elevated potassium levels may simply reflect a marker of another pathophysiologic process associated with atherosclerosis, such as renal dysfunction or myocardial ischemia. Although our analyses attempted to control for such comorbidities, it is possible that very minor degrees of renal dysfunction (potentially associated with atherosclerosis) may result in slight elevations of serum potassium that are within the so-called normal range. Finally, it conceivable that the entire relationship may be a spurious one, although we believe that the rigor of the analyses make this scenario unlikely. In addition, we believe that the association of other conventional risk factors as well as several inflammatory markers with CAD in our population serve as a validation of our dataset. To this point, and as already stated, the finding that potassium levels were associated with CAD independent of markers of inflammation (such as myeloperoxidase or WBC) suggest that the association of K may not be related to inflammation per se. Finally, it is noteworthy that the independent association between serum potassium levels and atherosclerosis persisted in the non-MI subpopulation, but was not seen in the MI subpopulation. This may simply represent a sample size issue. However, it is also conceivable that the low serum potassium concentrations seen in MI 11, 12 may obscure the predictive value of elevated potassium levels in chronic and stable patients.
There are several limitations to the present study. First, the study was exploratory and observational in nature and as such is subject to the limitations of this type of analysis. Second, our scoring system was at best a very crude assessment of true atherosclerotic burden. We did not perform intravascular ultrasound, quantitative coronary angiography or a detailed analysis of all segments (such as the Gensini scoring system). We believe, however, that our scoring systems more closely reflects current practice patterns both in the United States and abroad. A third limitation of our study was the heterogeneous nature of the population. However, this can also be considered a strength as it may reflect a "real world" population referred for coronary angiography. Fourth, our study population was restricted to males, and it is unknown whether the study findings can be applied to females. Fifth, we used the Modification of Diet in Renal Disease equation (a method of glomerular filtration rate estimation that was originally derived from patients with chronic kidney disease) to estimate glomerular filtration rate even though the majority of subjects in this study had normal renal function. However, the Modification of Diet in Renal Disease equation takes into account race and we felt that this was an important variable in our study population since approximately one-third of the participants were African American. Finally, as this study was exploratory and not hypothesis driven, the possibility exists that the findings could indeed have occurred by chance.
In summary, we have demonstrated that baseline serum potassium levels are independently associated with the presence of multivessel CAD in a broad and unselected population of patients referred for coronary angiography. Importantly, this association persisted even after adjustment for many conventional variables known to be associated with atherosclerosis. Further studies are needed to replicate these findings and, if confirmed, to elucidate both the clinical implications and the mechanism(s) of this association.
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